Diagnosing and Treating Excessive
Daytime Sleepiness in Narcolepsy or Obstructive Sleep Apnea
A continuing medical education
activity provided by NAMCP and AAMCN
This activity is an archive from the live session from the 2021 Fall
Managed Care Forum.
If you participated in the live session, you are not eligible for
education credits from this archive.
This activity is valid from January 1, 2022, to March 1, 2023.
Instructions for CME/NCPD: Complete the pre-test, listen to the
audio and view the slides, complete the post test, complete the
evaluation form and hit submit. You will be asked to enter your name
and email address on the pre-test, evaluation and post-test. If you
close your internet browser without completing the post test, you
will have ONE more opportunity to complete. A score of 70% must be
achieved on the post test to receive continuing education credits.
If you do not pass the post test after two attempts, you will not be
eligible to try again. Once you complete the evaluation form and
score 70% or higher on your post test, you will automatically be
given your certificate.
To print or save your certificate, you will need to click on the
“download” button and either print or save.
This activity is intended for healthcare professionals practicing in
managed care environments.
This activity is supported by an
educational grant from
Narcolepsy and OSA can interfere with psychological, social, and
cognitive function and development and can inhibit academic, work,
and social activities. With the potential danger surrounding
narcoleptic patients, it is important for clinicians to understand
and identify major sleep disorders and the best methods to diagnose
and treat them. Greater awareness of sleep disorders and its
symptoms can help accurately and efficiently diagnosis the disease.
As research continues to grow, better treatments for narcolepsy are
becoming available. Sleep studies are an essential part of the
evaluation and diagnosis of patients with narcolepsy. While in most
instances imaging studies do not give an accurate picture of what is
going on, a few studies done with an MRI can show structural
abnormalities of the brain that will help show what may be the
underlying cause of the sleep disorder. Symptoms can include EDS,
sleep paralysis, hallucinations, but cataplexy is the most specific
symptom and occurs in almost no other diseases. The combination of
an overnight polysomnogram (PSG) followed by a multiple sleep
latency test (MSLT) can provide the proper evidence of narcolepsy
while excluding other sleep disorders. This activity will focus on
an understanding of novel therapies for EDS in OSA and narcolepsy
and how to incorporate this evidence into optimal treatment planning
to reduce the burden of EDS. With recent evidence and data are
showing a lot of promise, there needs to be more education on the
best treatment strategies available. By navigating recent clinical
trial data on these therapies, the attendees should be better able
to apply the latest evidence to practice, optimizing the management
of EDS in patients with narcolepsy and OSA. Given the limitations in
safety and efficacy of more traditional therapies for EDS, there is
a need for novel therapies and the best methods to manage them.
Upon completion of this
activity, participants will be able to:
Discuss the mechanisms, prevalence,
and impact of excessive daytime sleepiness (EDS) in patients
Assess evidence-driven strategies
for diagnosing and treating excessive daytime sleepiness in
narcolepsy and obstructive sleep apnea (OSA)
Analyze the latest clinical evidence
on current and novel therapies for EDS in OSA and narcolepsy
into optimal treatment planning to reduce the illness burden
Discuss the role of a
multidisciplinary team to help incorporate the latest clinical
evidence on novel therapies for EDS
Enhance the quality-of-life
implications of EDS to educate patients about the significance
of detection and treatment
||Suresh Kotagal, MD
Professor Emeritus, Department of Neurology
Consultant in Neurology, Pediatrics, and Sleep Medicine
has served on the Data Safety Monitoring Board for Suven.
His presentation has been peer reviewed for any bias.
MD has no financial relationships with ineligible
companies to disclose.
Jeremy Williams has no financial relationships with
ineligible companies to disclose.
Jacqueline Cole, RN, MS, CMCN has no financial
relationships with ineligible companies to disclose.
NAMCP and/or the presenter
has copyright or has received permissions for use of
materials provided in this activity.
Accreditation & Designation
This activity has been planned and implemented in accordance with
the accreditation requirements and policies of the Accreditation
Council for Continuing Medical Education (ACCME) through the joint
providership of the National Association of Managed Care Physicians
(NAMCP) and American Association of Managed Care Nurses (AAMCN). The
National Association of Managed Care Physicians is accredited by the
ACCME to provide continuing medical education for physicians.
NAMCP designates this enduring material for a maximum of 1 AMA
PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their
participation in the activity.
The American Association of Managed Care Nurses is accredited as a
provider of nursing continuing professional development by the
American Nurses Credentialing Center's Commission on Accreditation.
Nurses who complete this activity and achieve a passing score will
receive 1 hour in nursing continuing professional development.
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
This activity is supported by an educational grant from
NAMCP and/or this website does not
provide medical advice, diagnosis or treatment. NAMCP does not
endorse or imply endorsement of the content on any linked website.
This website is to be used as an informational resource. With any
health related concern, consult with your physician or healthcare
Click Here To Continue